Medicare Enrolled

Dr. Shawna Weisler, M.D

Optician · Burbank, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3808 W RIVERSIDE DR STE 406, Burbank, CA 91505
8184322392
In practice since 2006 (19 years)
NPI: 1962501858 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Weisler from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Weisler? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Weisler

Dr. Shawna Weisler is an optician specialist in Burbank, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Weisler performed 1,875 Medicare services across 694 unique beneficiaries.

Between the years covered by Open Payments, Dr. Weisler received a total of $99,561 from 49 pharmaceutical and/or device companies across 810 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Weisler is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 38% volume in CA $99,561 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,875
Medicare services
Top 38% in CA for optician
694
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~99 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 900 $19 $50
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
543 $93 $317
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
182 $28 $137
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
67 $134 $437
New patient office visit, complex (60-74 min) 61 $180 $476
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
36 $71 $257
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
30 $13 $62
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
20 $3 $9
Continuous glucose monitoring, tissue fluid
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin.
19 $57 $251
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
17 $143 $453
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$99,561
Total received (2018-2024)
Avg $14,223/year across 7 years
Top 3% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
810
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$83,693 (84.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,351 (13.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,517 (2.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$385
2023
$1,440
2022
$2,748
2021
$11,032
2020
$10,811
2019
$16,806
2018
$56,339

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$140
Abbott Laboratories
$111
Antares Pharma, Inc.
$51
CeQur Corporation
$26
SANOFI-AVENTIS U.S. LLC
$22
Tandem Diabetes Care, Inc.
$22
Xeris Pharmaceuticals, Inc.
$13
Top 3 companies account for 78.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$71,217
Dexcom, Inc.
$12,764
Novo Nordisk Inc
$3,802
DEXCOM, INC.
$2,517
Lilly USA, LLC
$967
SANOFI-AVENTIS U.S. LLC
$878
Mannkind Corporation
$821
MannKind Corporation
$748
Abbott Laboratories
$632
Boehringer Ingelheim Pharmaceuticals, Inc.
$531
Amgen Inc.
$523
AbbVie, Inc.
$403
Companion Medical, Inc.
$326
Radius Health, Inc.
$322
Merck Sharp & Dohme Corporation
$292
IBSA Pharma Inc.
$237
Medtronic MiniMed, Inc.
$231
Antares Pharma, Inc.
$212
AbbVie Inc.
$208
Valeritas, Inc.
$149
Tandem Diabetes Care, Inc.
$147
Zealand Pharma US, Inc.
$140
Amarin Pharma Inc.
$131
Bayer Healthcare Pharmaceuticals Inc.
$130
Shire North American Group Inc
$111
Kowa Pharmaceuticals America, Inc.
$92
ABBVIE INC.
$86
EISAI INC.
$84
Corcept Therapeutics
$84
Insulet Corporation
$79
Currax Pharmaceuticals LLC
$66
Becton, Dickinson and Company
$63
Supernus Pharmaceuticals, Inc.
$60
Alfasigma USA, Inc.
$54
VistaPharm, Inc.
$51
Biogen, Inc.
$42
Medtronic, Inc.
$41
Alexion Pharmaceuticals, Inc.
$41
Janssen Pharmaceuticals, Inc
$30
Embecta Corp.
$30
Eisai Inc.
$29
Kyowa Kirin, Inc.
$29
Regeneron Healthcare Solutions, Inc.
$27
Xeris Pharmaceuticals, Inc.
$27
CeQur Corporation
$26
VIVUS LLC
$25
Amryt Pharma Holdings Ltd
$21
Orexigen Therapeutics, Inc.
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
Top 3 companies account for 88.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BD Ultra-Fine · BYDUREON · Belviq · CONTRAVE · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Freedom Lite system · FreeStyle Libre · FreeStyle Libre 2 · GVOKE HYPOPEN · Guardian Connect · HUMULIN · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LICART · LINZESS · Licart · Livalo · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NOCDURNA · Omnipod · Otrexup · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QSYMIA · RECORLEV · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Strensiq · Synthroid · TLANDO · TOUJEO · TRADJENTA · TRULICITY · Thyquidity · Tirosint · Tresiba · Tymlos · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · ZEGALOGUE · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for optician in CA.

Looking for an optician specialist in Burbank?
Compare opticians in the Burbank area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
1,393
Per 100K population
14.1
County median income
$87,760
Nearest hospital
PROVIDENCE SAINT JOSEPH MEDICAL CTR
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Weisler is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 3% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Weisler experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Weisler performed 900 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Weisler receive payments from pharmaceutical companies?
Yes. Dr. Weisler received a total of $99,561 from 49 companies across 810 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Weisler's costs compare to other opticians in Burbank?
Dr. Weisler's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Weisler) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →